Moreover, serotonin transporter (SERT) levels worsened the depression symptoms, and studies revealed that raphe nuclei and limbic structures showed increased SERT binding in PD patients with depression than those without depressive symptoms. This evidence concerns the gene SLC6A4 and depressive symptom measurement.